Skip to main content

Advertisement

Log in

Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis

Six new cases and a literature review

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

There are increasing data suggesting the involvement of the immune system in narcolepsy. The co-occurrence of narcolepsy with other autoimmune disorders (including multiple sclerosis, MS) is rare.

Patients and methods

International multicenter sleep center survey and literature review on narcolepsy with (NC) and without (NwC) cataplexy.

Results

A total of 26 patients (pts), 6 in the survey and 20 in the literature were found. Two different types of association were identified: (1) Symptomatic type (5 pts): MS preceding the onset of narcolepsy, which was always without cataplexy (NwC); sleep onset REM episodes (SOREM) and hypocretin deficiency were observed in some, and lesions in the hypothalamus in all patients. (2) Coexisting type (18 pts): MS preceding or following the appearance of NC with SOREM, hypocretin deficiency but no lesions in the hypothalamus. A positive effect of steroids, immunoglobulins or natalizumab on narcolepsy symptoms was observed in four patients.

Discussion

Narcolepsy and MS are rarely associated. In addition to NwC secondary to hypothalamic demyelination, some patients present a coexistence of MS with NC without detectable hypothalamic lesions. The rarity of reports on this association probably reflects underrecognition. The elucidation of underlying genetic and immune mechanisms needs further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Koskimies S, Guilleminault C (1994) The prevalence of narcolepsy: an epidemiological study of the finnish twin cohort. Ann Neurol 35:709–716

    Article  PubMed  CAS  Google Scholar 

  2. Silber MH, Krahn LE, Olson EJ, Pankratz VS (2002) The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25:197–202

    Article  PubMed  Google Scholar 

  3. Goldbart A, Peppard P, Finn L, Ruoff CM, Barnet J, Young T, Mignot E (2014) Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep 37:1043–1051

    Article  PubMed  PubMed Central  Google Scholar 

  4. Liblau RS, Vassalli A, Seifi A, Tafti M (2015) Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 14:318–328

    Article  PubMed  CAS  Google Scholar 

  5. Andlauer O, Moore H IV, Hong SC et al (2012) Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 35:1247–1255

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bernard-Valnet R, Yshii L, Quériault C et al (2016) CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci USA 113:10956–10961

    Article  PubMed  CAS  Google Scholar 

  7. Kamm CP, Uitdehaag BM, Polman CH (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72:132–141

    Article  PubMed  CAS  Google Scholar 

  8. Schmidt H, Williamson D, Ashley-Koch A (2007) HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 165:1097–1109

    Article  PubMed  Google Scholar 

  9. Brass SD, Li CS, Auerbach S (2014) The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 10:1025–1031

    PubMed  PubMed Central  Google Scholar 

  10. Barateau L, Lopez R, Arnulf I et al (2017) Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology 88:93–100

    Article  PubMed  Google Scholar 

  11. Nishino S, Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9:269–310

    Article  PubMed  Google Scholar 

  12. Silber MH (2016) Autoimmune sleep disorders. Handb Clin Neurol 133:317–326

    Article  PubMed  Google Scholar 

  13. Ekbom K (1966) Familial multiple sclerosis associated with narcolepsy. Arch Neurol 15:337–344

    Article  PubMed  CAS  Google Scholar 

  14. Lorenzoni PJ, Werneck LC, Crippa AC et al (2017) Is there a relationship between narcolepsy, multiple sclerosis and HLA-DQB1*06:02? Arq Neuropsiquiatr 75:345–348

    Article  PubMed  Google Scholar 

  15. Jennum PJ, Kornum BR, Issa NM,et al (2016) Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e249

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hor H, Kutalik Z, Dauvilliers Y et al (2010) Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 42:786–789

    Article  PubMed  CAS  Google Scholar 

  17. Moutsianas L, Jostins L, Beecham AH et al (2015) Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet 47:1107–1113

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Zivadinov R, Uxa L, Bratina A et al (2007) HLA-DRB1*1501,-DQB1*0301,-DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with Multiple Sclerosis. Int Rev Neurobiol 79:521–535

    Article  PubMed  CAS  Google Scholar 

  19. Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G (2014) DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37:19–25

    Article  PubMed  PubMed Central  Google Scholar 

  20. Zandian A, Forsström B, Häggmark-Månberg A et al (2017) Whole-proteome peptide microarrays for profiling autoantibody repertoires within multiple sclerosis and narcolepsy. J Proteome Res 16:1300–1314

    Article  PubMed  CAS  Google Scholar 

  21. Zabad RK, Stewart R, Healey KM (2017) Pattern recognition of the multiple sclerosis syndrome. Brain Sci 7:E138

    Article  PubMed  Google Scholar 

  22. Hor H, Bartesaghi L, Kutalik Z et al (2011) A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am J Hum Genet 89:474–479

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Latorre D, Kallweit U, Armentani E et al. Autoreactive T cells in narcolepsy patients target antigens of hypocretin-producing neurons (Review)

  24. Penner I-K, Sivertsdotter EC, Celius EG et al (2015) Improvement in fatigue during natalizumab treatment is linked to improvement in depression and day-time sleepiness. Front Neurol 6:18

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater P (2016) NAPS-MS: natalizumab effects on parameters of sleep in patients with multiple sclerosis. Int J MS Care 18:177–182

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudio L. A. Bassetti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kallweit, U., Bassetti, C.L.A., Oberholzer, M. et al. Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis. J Neurol 265, 2071–2078 (2018). https://doi.org/10.1007/s00415-018-8949-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-018-8949-x

Keywords

Navigation